Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For VIAV
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 23.14 3.81 3.09
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1648.16 104.36 5.97
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value -3.36 3.16 3.27
Cash -14.72 2.18 2.56
Capex 44.95 -0.01 -0.03
Free Cash Flow 11.39 0.07 0.07
Revenue -3.56 1.10 1.14
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin -4.65 0.55 0.58
Operating Margin -42.73 -0.05 0.09
ROA 144.70 -0.01 < 0.005
ROE 137.37 -0.03 0.01
ROIC 67.05 -0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of VIAV is permitted for members.
5 Growth
The "Growth Entry" for the Focus of VIAV is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of VIAV is permitted for members.